ESTRAMUSTINE PHOSPHATE (has an active metabolite) | ESTRAMUSTINE PHOSPHATE | ATC L01XX11
ANTINEOPLASTIC ALKYLATING TREATMENT OF PATIENTS WITH METASTATIC AND/OR PROGRESSIVE CARCINOMA OF THE PROSTATE | ORAL | Tmax 2 HOUR F 70 PERCENT VD 7.8 LITER (65 KILOGRAM) Cl 3.6 LITER / HOUR (65 KILOGRAM) HT 2.4 HOUR SOLUBILITY READILY SOLUBLE IN WATER | ESTROGEN RECEPTOR | DNA INHIBITOR CHEMBL2311221 DNA Q92731 ESTROGEN RECEPTOR BETA HOMO SAPIENS TRANSCRIPTION FACTOR NUCLEAR RECEPTOR NR3 NR3A NR3A2 | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |